Nifty

:

22620.40

Sensex

:

74398.48

50.05 (0.22%)
59.04 (0.08%)

Login

Nifty
Sensex

:
:

22620.40
74398.48

50.05 (0.22%)
59.04 (0.08%)

Celestial Biolabs Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 532871 | NSE: CELESTIAL

Watchlist

NSE BSE

Not traded in the last 30 days

Open
High
Low
Previous Close

N/A
N/A
N/A
N/A

Volume
Traded Value (lacs)
52 Week High
52 Week Low

N/A
N/A
N/A
N/A

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4.56
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

13.97
N/A
N/A

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-39.04
-67.72
-

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 0.04 0.03 33.33% 0.04 0.04 0.00% 0.02 0.06 -66.67% 0.04 0.06 -33.33%
Expenses 0.07 0.18 -61.11% 0.06 0.12 -50.00% 0.12 0.15 -20.00% 0.27 0.33 -18.18%
EBITDA -0.03 -0.15 - -0.03 -0.07 - -0.09 -0.09 - -0.23 -0.27 -
EBIDTM -78.38% -429.41% -75.00% -176.19% -400.00% -170.91% -602.63% -425.40%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.01 0.01 0.00% 0.01 0.01 0.00% 0.01 0.01 0.00% 0.01 0.01 0.00%
PBT -0.03 -0.15 - -0.03 -0.08 - -0.10 -0.10 - -0.24 -0.28 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT -0.03 -0.15 - -0.03 -0.08 - -0.10 -0.10 - -0.24 -0.28 -
PATM -94.59% -452.94% -88.89% -195.24% -421.74% -183.64% -621.05% -436.51%
EPS -0.02 -0.07 - -0.01 -0.04 - -0.04 -0.04 - -0.10 -0.12 -

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 0.04 0.03 33.33% 0.04 0.04 0.00% 0.02 0.06 -66.67% 0.04 0.06 -33.33%
Expenses 0.07 0.18 -61.11% 0.06 0.12 -50.00% 0.12 0.15 -20.00% 0.27 0.33 -18.18%
EBITDA -0.03 -0.15 - -0.03 -0.07 - -0.09 -0.09 - -0.23 -0.27 -
EBIDTM -86.49% -429.41% -77.78% -176.19% -400.00% -170.91% -610.53% -425.40%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.01 0.00 0
Depreciation 0.01 0.01 0.00% 0.01 0.01 0.00% 0.01 0.01 0.00% 0.01 0.01 0.00%
PBT -0.04 -0.15 - -0.03 -0.08 - -0.10 -0.10 - -0.25 -0.28 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT -0.04 -0.15 - -0.03 -0.08 - -0.10 -0.10 - -0.25 -0.28 -
PATM -102.70% -452.94% -91.67% -195.24% -426.09% -185.45% -644.74% -436.51%
EPS -0.02 -0.07 - -0.01 -0.04 - -0.04 -0.05 - -0.11 -0.12 -

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 22 Mar 21 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 0.14 0.15 0.00 42.81 38.66 32.86 27.45 23.50 21.16 20.59 25.22 Net Sales Growth -26.32% 0 -100% 10.73% 17.65% 19.71% 16.81% 11.06% 2.77% -18.36% Cost Of Goods Sold 0.09 0.06 0.00 28.64 24.38 16.04 5.43 8.87 8.62 6.99 10.73 Gross Profit 0.05 0.09 0.00 14.18 14.29 16.82 22.02 14.63 12.53 13.60 14.49 GP Margin 35.00% 60.0% 0 33.12% 36.96% 51.19% 80.22% 62.26% 59.22% 66.05% 57.45% Total Expenditure 0.52 0.49 0.16 30.99 31.67 24.30 15.02 15.75 15.47 16.33 19.14 Power & Fuel Cost - 0.00 0.02 0.12 0.09 0.09 0.02 0.02 0.02 0.03 0.04 % Of Sales - 0% 0 0.28% 0.23% 0.27% 0.07% 0.09% 0.09% 0.15% 0.16% Employee Cost - 0.12 0.03 0.63 1.08 0.92 -11,998.99 0.76 1.01 1.10 3.17 % Of Sales - 80.0% 0 1.47% 2.79% 2.80% -43712.17% 3.23% 4.77% 5.34% 12.57% Manufacturing Exp. - 0.04 0.00 0.88 4.78 4.33 1.86 1.37 1.48 3.26 3.16 % Of Sales - 26.67% 0 2.06% 12.36% 13.18% 6.78% 5.83% 6.99% 15.83% 12.53% General & Admin Exp. - 0.26 0.11 0.49 0.39 1.24 12,000.65 0.34 2.31 1.00 0.38 % Of Sales - 173.33% 0 1.14% 1.01% 3.77% 43718.21% 1.45% 10.92% 4.86% 1.51% Selling & Distn. Exp. - 0.01 0.00 0.14 0.87 1.58 3.52 2.31 2.02 2.22 0.61 % Of Sales - 6.67% 0 0.33% 2.25% 4.81% 12.82% 9.83% 9.55% 10.78% 2.42% Miscellaneous Exp. - 0.00 0.00 0.08 0.09 0.10 2.53 2.07 0.00 1.74 0.61 % Of Sales - 0% 0 0.19% 0.23% 0.30% 9.22% 8.81% 0% 8.45% 4.16% EBITDA -0.38 -0.34 -0.16 11.82 6.99 8.56 12.43 7.75 5.69 4.26 6.08 EBITDA Margin -271.43% -226.67% 0 27.61% 18.08% 26.05% 45.28% 32.98% 26.89% 20.69% 24.11% Other Income 0.00 0.00 0.03 0.00 0.00 0.29 0.00 0.00 0.04 0.43 0.11 Interest 0.00 0.04 0.00 0.03 0.02 1.29 4.15 2.22 0.69 0.67 0.25 Depreciation 0.04 0.03 0.04 7.70 3.30 5.71 7.06 4.98 4.73 3.73 3.15 PBT -0.40 -0.41 -0.17 4.11 3.67 1.85 1.23 0.55 0.31 0.28 2.79 Tax 0.00 0.00 0.00 0.65 0.34 -0.23 -0.07 -0.29 -0.40 -0.63 0.37 Tax Rate 0.00% 0.00% 0.00% 15.82% 9.26% -12.43% -5.69% -52.73% -129.03% -225.00% 13.26% PAT -0.40 -0.41 -0.17 3.46 3.33 2.08 1.30 0.84 0.71 0.92 2.42 PAT before Minority Interest -0.40 -0.41 -0.17 3.46 3.33 2.08 1.30 0.84 0.71 0.92 2.42 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -285.71% -273.33% 0 8.08% 8.61% 6.33% 4.74% 3.57% 3.36% 4.47% 9.60% PAT Growth 0.00% - - 3.90% 60.10% 60.00% 54.76% 18.31% -22.83% -61.98% EPS -0.18 -0.18 -0.08 1.53 1.47 0.92 0.58 0.37 0.31 0.41 1.07

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 3.35 3.76 102.30 98.84 95.51 86.62 85.60 79.26 78.55 77.63 Share Capital 22.59 22.59 22.59 22.59 20.49 18.56 17.35 14.60 14.60 14.60 Total Reserves -19.24 -18.83 79.71 76.26 69.57 62.25 68.25 64.66 63.95 63.03 Non-Current Liabilities 8.49 8.23 9.39 8.35 7.79 11.05 18.26 15.44 13.32 12.31 Secured Loans 0.23 0.23 4.60 7.60 7.60 7.60 16.06 13.92 12.09 10.38 Unsecured Loans 8.26 8.00 4.82 0.65 0.65 3.57 2.38 1.30 0.56 0.56 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 5.34 5.19 2.26 1.35 1.69 1.44 0.56 0.62 0.45 1.16 Trade Payables 0.26 0.38 0.43 0.42 0.69 0.65 0.37 0.26 0.21 0.15 Other Current Liabilities 2.03 1.75 0.28 0.15 0.55 0.48 0.00 0.30 0.17 0.42 Short Term Borrowings 3.05 3.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 0.00 0.00 1.55 0.78 0.46 0.32 0.18 0.06 0.08 0.59 Total Liabilities 17.18 17.18 113.95 108.54 104.99 99.11 104.42 95.32 92.32 91.10 Net Block 0.10 0.13 53.10 60.85 26.45 27.78 36.82 39.30 40.50 30.84 Gross Block 11.85 11.84 102.55 103.46 65.75 61.39 63.36 53.38 49.84 36.45 Accumulated Depreciation 11.74 11.71 49.45 42.61 39.31 33.60 26.54 14.08 9.35 5.61 Non Current Assets 12.92 12.94 82.96 90.71 56.31 52.97 61.50 61.92 61.49 67.47 Capital Work in Progress 12.82 12.82 29.56 29.56 29.56 25.19 24.68 22.62 20.99 36.63 Non Current Investment 0.00 0.00 0.30 0.30 0.30 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 4.26 4.23 31.00 17.84 48.69 46.14 42.92 33.40 30.83 23.63 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.87 Inventories 0.05 0.05 3.96 7.72 9.66 12.71 7.27 5.30 4.88 4.01 Sundry Debtors 3.83 3.78 20.77 8.25 11.95 9.00 9.04 5.79 5.26 4.60 Cash & Bank 0.00 0.02 0.01 0.41 0.92 0.85 0.55 0.17 0.17 0.07 Other Current Assets 0.38 0.22 5.58 0.78 26.16 23.59 26.05 22.15 20.53 14.10 Short Term Loans & Adv. 0.16 0.16 0.68 0.68 1.48 0.79 0.72 1.40 0.86 0.69 Net Current Assets -1.08 -0.96 28.74 16.49 46.99 44.70 42.36 32.78 30.38 22.48 Total Assets 17.18 17.17 113.96 108.55 105.00 99.11 104.42 95.32 92.32 91.10

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity -0.28 -0.03 3.34 13.40 8.02 5.79 3.27 3.22 3.22 1.03 PBT -0.41 -0.17 4.11 3.67 1.85 1.23 0.55 0.28 0.28 2.79 Adjustment 0.03 0.04 7.07 2.98 7.12 11.27 7.49 5.04 5.04 3.50 Changes in Working Capital 0.10 0.10 -7.84 6.75 -0.95 -6.71 -4.77 -2.10 -2.10 -4.69 Cash after chg. in Working capital -0.28 -0.03 3.34 13.40 8.02 5.79 3.27 3.22 3.22 1.60 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.57 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 0.00 0.00 -4.88 -13.89 -11.61 -3.60 -8.19 -4.17 -4.17 -16.49 Net Fixed Assets -0.01 107.45 0.91 -37.71 -8.73 1.46 -12.04 -5.17 2.25 -15.24 Net Investments 0.00 0.30 0.00 0.00 -0.30 0.00 0.00 0.00 0.87 3.28 Others 0.01 -107.75 -5.79 23.82 -2.58 -5.06 3.85 1.00 -7.29 -4.53 Cash from Financing Activity 0.26 0.05 1.14 -0.02 3.66 -1.88 5.29 1.04 1.04 11.31 Net Cash Inflow / Outflow -0.02 0.01 -0.40 -0.51 0.07 0.30 0.38 0.10 0.10 -4.16 Opening Cash & Equivalents 0.02 0.01 0.41 0.92 0.85 0.55 0.17 0.07 0.07 4.23 Closing Cash & Equivalent 0.00 0.02 0.01 0.41 0.92 0.85 0.55 0.17 0.17 0.07

Financial Ratios

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 1.48 1.66 45.29 43.76 43.96 43.55 49.33 54.28 53.79 53.16 ROA -2.38% -1.00% 3.11% 3.12% 2.04% 1.27% 0.85% 0.76% 1.00% 2.88% ROE -11.52% -4.46% 3.44% 3.53% 2.43% 1.56% 1.02% 0.90% 1.17% 3.56% ROCE -2.46% -1.13% 3.78% 3.50% 3.12% 5.33% 2.79% 1.07% 1.07% 3.94% Fixed Asset Turnover 0.01 0.00 0.42 0.46 0.52 0.44 0.40 0.41 0.48 0.71 Receivable days 9419.47 0.00 123.72 95.37 116.38 119.96 115.17 95.33 87.37 42.91 Inventory Days 124.84 0.00 49.77 82.04 124.25 132.79 97.60 87.80 78.77 45.00 Payable days 1878.19 0.00 4.61 6.11 7.12 13.15 5.80 4.69 3.53 2.93 Cash Conversion Cycle 7666.12 0.00 168.87 171.31 233.50 239.61 206.97 178.45 162.61 84.98 Total Debt/Equity 3.44 3.00 0.09 0.08 0.09 0.14 0.22 0.19 0.16 0.14 Interest Cover -8.94 0.00 162.76 204.01 2.44 1.30 1.25 1.45 1.42 12.19

Top Investors:

ajay kumar singh

chandrashekhar ram vaidya

Annual Reports:

News Update:

Celestial Biolabs - Quarterly Results
29th Mar 2024, 19:04 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback